A rare case of late presentation of dasatinib-induced cardiopulmonary toxicity

A rare case of late presentation of dasatinib-induced cardiopulmonary toxicity

Tyrosine kinase inhibitors (TKI) (imatinib, dasatinib, and nilotinib) are used for the treatment and long-term control of chronic myeloid leukemia (CML). TKIs rarely cause systemic side effects with atypical presentations, and these must be borne in mind while prescribing these drugs over a prolonge...

Full description

Bibliographic Details
Main Authors: Harshit Khurana, Vijoy Kumar Jha, Ajay Handa, Debasish Mahapatra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Respiratory Care
Subjects:
cardiopulmonary toxicity
chronic myeloid leukemia
tyrosine kinase inhibitors
Online Access:http://www.ijrc.in/article.asp?issn=2277-9019;year=2021;volume=10;issue=1;spage=152;epage=155;aulast=

Similar Items

Similar Items